Soligenix Aktie
WKN DE: A2AS7Q / ISIN: US8342233074
18.08.2025 21:26:01
|
Soligenix Stock Jumps 92% After FDA Grants Orphan Drug Designation
(RTTNews) - Soligenix, Inc. (SNGX) surged 92.15 percent to $5.34, up $2.56 on Monday, after announcing that the FDA granted orphan drug designation to dusquetide, the active ingredient in SGX945, for the treatment of Behçet's Disease. The decision follows encouraging Phase 2a trial results showing biological efficacy and safety in patients. The stock opened at $3.79 and traded between $3.57 and $6.23, with volume spiking to 169.53 million shares, far above its average of 8.06 million on the Nasdaq. Soligenix's 52-week range is between $1.09 and $6.23.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Soligenix Inc Registered Shs (Old)mehr Nachrichten
Keine Nachrichten verfügbar. |